AKO-004

N/A

Report date: 2023/01/07 22:56:52
NME

Base Information

Drug NameAKO-004
Drug Alias NameAKO-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsApoptosis stimulants
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkome Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAkome Biotech Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A